
Nkarta Therapeutics, Inc
Get Full AccessDescription
- Nkarta Therapeutics, Inc.is a private biotech start-up that is harnessing the power of Natural Killer cells in developing next generation cellular immunotherapies for cancer. NK cells play a key role in the bodys immune system, able to identify and kill abnormal cells by monitoring their expression of activating and inhibitory receptors and recruit the adaptive immune system. Nkarta will combine its NK expansion platform with further proprietary cell engineering technologies to build differentiated products designed to tackle challenging diseases with significant unmet clinical need.
-
Headquarters:6000 Shoreline Court , South San Francisco, California, United States
More -
Phone Number: +1 650-351-7008
-
Website: https://www.nkartatx.com
-
Employees:74
-
Revenue:$50 - 100M
-
Legal Name:Nkarta Therapeutics, Inc
-
Nkarta Therapeutics, Inc's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Nkarta Therapeutics, Inc
-
Where are Nkarta Therapeutics, Inc's Headquarters?
Nkarta Therapeutics, Inc's Headquarters are in 6000 Shoreline Court ,South San Francisco,California,United States
-
What is Nkarta Therapeutics, Inc's phone number?
Nkarta Therapeutics, Inc's phone number is +1 650-351-7008
-
What is Nkarta Therapeutics, Inc's official website?
Nkarta Therapeutics, Inc's official website is https://www.nkartatx.com
-
What is Nkarta Therapeutics, Inc's Revenue?
Nkarta Therapeutics, Inc's revenue is $50 - 100M
-
What is Nkarta Therapeutics, Inc's NAICS code?
Nkarta Therapeutics, Inc's NAICS code is 541713
-
How many employees are working in Nkarta Therapeutics, Inc
Nkarta Therapeutics, Inc has 74 employees
-
What is Nkarta Therapeutics, Inc's Industry?
Nkarta Therapeutics, Inc is in the industry of Biotechnology
-
Who is Nkarta Therapeutics, Inc's CEO?
Nkarta Therapeutics, Inc's CEO is Paul Hastings